| Kristina A Jones-parker, FNP | |
|
138 Dublin Square Rd Ste B, Asheboro, NC 27203-8601 | |
| (336) 610-1300 | |
| Not Available |
| Full Name | Kristina A Jones-parker |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 138 Dublin Square Rd Ste B, Asheboro, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063757144 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 659259 (New York) | Secondary |
| 363L00000X | Nurse Practitioner | 5012900 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health | Durham, NC | Home health agency |
| Liberty Home Care | Lumberton, NC | Home health agency |
| Amedisys Home Health Care | Thomasville, NC | Home health agency |
| 3hc | Goldsboro, NC | Home health agency |
| Firsthealth Moore Regional Hospital | Pinehurst, NC | Hospital |
| St Joseph Of The Pines Health Center | Pinehurst, NC | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Horizon Internal Medicine Pllc | 0446391544 | 8 |
News Archive
A bill in the Virginia state legislature could upend a critical provision of the Democrats' health overhaul and open the door for a fresh battle over the federal government's power over states, The Boston Globe reports.
PharmaEngine, Inc. today announced that a New Drug Application (NDA) has been submitted to the Taiwan Food and Drug Administration (TFDA) for MM-398 (irinotecan liposome injection, also known as nal-IRI) in patients with metastatic adenocarcinoma of the pancreas who have been previously treated with gemcitabine-based therapy.
Two new studies have unveiled how a peculiar molecule impacts how antibody-producing cells develop and function as well as how normal melanocytes progress to melanoma malignancy.
The use of clot-busting drugs to clear blood from the brain's ventricles may be the first effective strategy to decrease mortality for a type of catastrophic bleeding stroke, according to phase-3 clinical trial results announced Thursday at the International Stroke Conference in Los Angeles.
› Verified 4 days ago
| Entity Name | Horizon Internal Medicine Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033353941 PECOS PAC ID: 0446391544 Enrollment ID: O20100112000441 |
News Archive
A bill in the Virginia state legislature could upend a critical provision of the Democrats' health overhaul and open the door for a fresh battle over the federal government's power over states, The Boston Globe reports.
PharmaEngine, Inc. today announced that a New Drug Application (NDA) has been submitted to the Taiwan Food and Drug Administration (TFDA) for MM-398 (irinotecan liposome injection, also known as nal-IRI) in patients with metastatic adenocarcinoma of the pancreas who have been previously treated with gemcitabine-based therapy.
Two new studies have unveiled how a peculiar molecule impacts how antibody-producing cells develop and function as well as how normal melanocytes progress to melanoma malignancy.
The use of clot-busting drugs to clear blood from the brain's ventricles may be the first effective strategy to decrease mortality for a type of catastrophic bleeding stroke, according to phase-3 clinical trial results announced Thursday at the International Stroke Conference in Los Angeles.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristina A Jones-parker, FNP 138 Dublin Square Rd Ste B, Asheboro, NC 27203-8601 Ph: (336) 610-1300 | Kristina A Jones-parker, FNP 138 Dublin Square Rd Ste B, Asheboro, NC 27203-8601 Ph: (336) 610-1300 |
News Archive
A bill in the Virginia state legislature could upend a critical provision of the Democrats' health overhaul and open the door for a fresh battle over the federal government's power over states, The Boston Globe reports.
PharmaEngine, Inc. today announced that a New Drug Application (NDA) has been submitted to the Taiwan Food and Drug Administration (TFDA) for MM-398 (irinotecan liposome injection, also known as nal-IRI) in patients with metastatic adenocarcinoma of the pancreas who have been previously treated with gemcitabine-based therapy.
Two new studies have unveiled how a peculiar molecule impacts how antibody-producing cells develop and function as well as how normal melanocytes progress to melanoma malignancy.
The use of clot-busting drugs to clear blood from the brain's ventricles may be the first effective strategy to decrease mortality for a type of catastrophic bleeding stroke, according to phase-3 clinical trial results announced Thursday at the International Stroke Conference in Los Angeles.
› Verified 4 days ago
Mr. Orlando Santiago Valenzuela Jr., AGNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 350 N Cox St Ste 6, Asheboro, NC 27203 Phone: 336-629-2201 | |
Marva Price, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2222 South Fayetteville Street, Randolph County Health Department, Asheboro, NC 27205 Phone: 336-318-3200 | |
Deanna Gay Markham, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 500 Albemarle Rd, Asheboro, NC 27203 Phone: 336-625-1172 | |
Dr. Susan A Fuller, DNP, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 300 Mack Rd, Asheboro, NC 27205 Phone: 336-625-1172 Fax: 336-625-6434 | |
Whitney Clendenin, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 138 Dublin Square Rd Ste B, Asheboro, NC 27203 Phone: 336-489-3100 | |
Jennifer Jean Linney, RN, FNP, AGACNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 138 Dublin Square Rd Ste B, Asheboro, NC 27203 Phone: 336-610-1300 | |
Fadielah Ruth Britt, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 610 N Fayetteville St Ste 300, Asheboro, NC 27203 Phone: 336-633-4020 |